# Primary endpoint

> The main outcome a clinical trial is designed and statistically powered to measure, used to judge whether the drug worked.

Source: https://www.quantisnow.com/glossary/primary-endpoint
Topic: Glossary / Biotech and FDA
Also known as: primary outcome measure, primary efficacy endpoint, met primary endpoint
Last updated: 2026-10-27

A primary endpoint is the main outcome a clinical trial is designed to measure, specified before the trial begins in the protocol and statistical analysis plan. Whether a trial "met its primary endpoint" is the standard test of success.

## How it works

The primary endpoint drives the trial's design, including how many patients are needed (statistical power). Common types:

- **Clinical outcomes:** overall survival, hospitalizations, heart attacks, strokes.
- **Symptom or function scores:** pain scales, disease activity indexes.
- **Surrogate endpoints:** biomarkers or measurements like tumor response, blood pressure or HbA1c that are expected to predict clinical benefit. Surrogates can support [accelerated approval](https://www.quantisnow.com/glossary/accelerated-approval).

Success is usually judged by statistical significance, most often a two-sided p-value below 0.05, meaning a result at least that large would be unlikely if the drug had no effect. Secondary endpoints are tested afterward, typically in a prespecified hierarchy so the overall false-positive rate stays controlled.

Changing the primary endpoint after a trial is underway, or highlighting a different one after the fact, is a red flag for regulators and investors.

## Why it matters for traders

The primary endpoint is the first line read in any [topline data](https://www.quantisnow.com/glossary/topline-data) release. Things to watch:

- **Statistical vs clinical significance.** A tiny but significant effect may not be commercially meaningful.
- **Endpoint acceptance.** Is it one the FDA has agreed can support approval?
- **Near misses.** A p-value of 0.06 is still a miss, even if the company emphasizes "trends".
- **Hierarchy.** If the primary misses, formal claims on secondary endpoints are generally off the table.

## Example

Northwind Therapeutics (NWTX) runs a 400-patient trial with a primary endpoint of change in a disease severity score at 24 weeks. The drug arm improves 12 points and placebo 8 points, a 4-point difference with p = 0.02. The trial met its primary endpoint, but analysts debate whether 4 points is clinically meaningful.

## FAQ

### What does "met the primary endpoint" mean?

The trial showed a statistically significant result on its main prespecified outcome, typically with a p-value below 0.05.

### What is the difference between primary and secondary endpoints?

The primary endpoint decides whether the trial succeeded. Secondary endpoints provide supporting evidence and are usually tested only if the primary is met.

## Related terms

- [Topline data](https://www.quantisnow.com/glossary/topline-data.md): The first high-level results from a clinical trial, usually covering the primary endpoint and key safety findings, released before the full dataset.
- [Phase 3 clinical trial](https://www.quantisnow.com/glossary/phase-3-trial.md): The large, late-stage trial that tests whether a drug works and is safe in a broad patient population, usually forming the basis for an FDA application.
- [Phase 2 clinical trial](https://www.quantisnow.com/glossary/phase-2-trial.md): The mid-stage of drug testing in patients, designed to show early evidence that a drug works, refine the dose and further assess safety.
- [Accelerated approval](https://www.quantisnow.com/glossary/accelerated-approval.md): An FDA pathway approving drugs for serious conditions based on a surrogate endpoint, with confirmatory trials required to verify clinical benefit.
- [New Drug Application (NDA)](https://www.quantisnow.com/glossary/nda.md): The formal application a drugmaker submits to the FDA requesting approval to market a new small-molecule drug in the United States.

## On Quantisnow

- [Clinical trial phases explained](https://www.quantisnow.com/guides/clinical-trial-phases)
- [Live feed: FDA Approvals](https://www.quantisnow.com/news/fda)
- [FDA approval process](https://www.quantisnow.com/guides/fda-approval-process)